Verastem, Inc. (VSTM)
10.01
+0.01
(+0.10%)
USD |
NASDAQ |
Oct 27, 14:48
Verastem Market Cap : 905.72M for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 904.82M |
| October 23, 2026 | 908.44M |
| October 22, 2026 | 910.24M |
| October 21, 2026 | 833.34M |
| October 20, 2026 | 845.10M |
| October 19, 2026 | 779.95M |
| October 16, 2026 | 782.67M |
| October 15, 2026 | 835.15M |
| October 14, 2026 | 697.61M |
| October 13, 2026 | 674.09M |
| October 12, 2026 | 746.47M |
| October 09, 2026 | 758.24M |
| October 08, 2026 | 733.81M |
| October 07, 2026 | 747.83M |
| October 06, 2026 | 701.23M |
| October 05, 2026 | 723.85M |
| October 02, 2026 | 696.71M |
| October 01, 2026 | 714.80M |
| September 30, 2026 | 728.38M |
| September 29, 2026 | 716.61M |
| September 28, 2026 | 703.04M |
| September 25, 2026 | 700.33M |
| September 24, 2026 | 705.76M |
| September 23, 2026 | 740.14M |
| September 22, 2026 | 757.33M |
| Date | Value |
|---|---|
| September 21, 2026 | 722.95M |
| September 18, 2026 | 673.18M |
| September 17, 2026 | 683.14M |
| September 16, 2026 | 662.33M |
| September 15, 2026 | 664.13M |
| September 14, 2026 | 679.52M |
| September 11, 2026 | 662.33M |
| September 10, 2026 | 689.47M |
| September 09, 2026 | 718.42M |
| September 08, 2026 | 731.09M |
| September 04, 2026 | 741.95M |
| September 03, 2026 | 722.04M |
| September 02, 2026 | 725.66M |
| September 01, 2026 | 688.56M |
| August 31, 2026 | 653.28M |
| August 28, 2026 | 653.28M |
| August 27, 2026 | 667.75M |
| August 26, 2026 | 668.66M |
| August 25, 2026 | 640.61M |
| August 24, 2026 | 620.70M |
| August 21, 2026 | 623.42M |
| August 20, 2026 | 617.08M |
| August 19, 2026 | 660.06M |
| August 18, 2026 | 672.28M |
| August 17, 2026 | 649.66M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cytokinetics, Inc. | 8.459B |
| United Therapeutics Corp. | 25.16B |
| SELLAS Life Sciences Group, Inc. | 2.449B |
| AbbVie, Inc. | 506.30B |
| Dianthus Therapeutics, Inc. | 4.341B |
Market Cap Related Metrics
| PS Ratio | 10.15 |
| Price to Book Value | 18.12 |
| Price | 10.01 |
| Earnings Yield | -24.58% |